
HALO Market Cap & Key Metrics
Halozyme Therapeutics, Inc.
$91.35
-$1.69(-1.82%)
56
Overall
60
Value
45
Tech
65
Quality
Market Cap
$10.41B
Volume
1.50M
52W Range
$61.23 - $134.00
Target Price
$116.50
HALO market cap is $10.41B. This page lists Halozyme Therapeutics, Inc.'s P/E ratio, EPS estimates, dividend yield, payout ratio and MarketXLS scores.
HALO Key Metrics
- Market cap
- $10.41B
- P/E ratio (current-year EPS estimate)
- 10.95
- EPS estimate, current year
- $8.34
- EPS growth, 3-year
- +21.28%
- Value score
- 60
- Quality score
- 65
- Technical score
- 45
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $1.40B | $1.02B | $829.25M | $660.12M | $443.31M |
| EBITDA | $573.05M | $663.89M | $459.27M | $323.35M | $259.04M |
| EPS | $2.64 | $3.50 | $2.13 | $1.48 | $2.86 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | HALO | $91.35 | -1.8% | 1.50M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Halozyme Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW